Hepatitis E virus seroprevalence, seroincidence and seroreversion in the German adult population

2018 ◽  
Vol 25 (6) ◽  
pp. 752-758 ◽  
Author(s):  
M. Faber ◽  
N. Willrich ◽  
M. Schemmerer ◽  
C. Rauh ◽  
R. Kuhnert ◽  
...  
2019 ◽  
Vol 208 (6) ◽  
pp. 715-725 ◽  
Author(s):  
Irene Beate Olsøy ◽  
Stian Henriksen ◽  
Fabian H. Weissbach ◽  
Marthe Larsen ◽  
Karoline Borgen ◽  
...  

2019 ◽  
Vol 208 (6) ◽  
pp. 887-887
Author(s):  
Irene Beate Olsøy ◽  
Stian Henriksen ◽  
Fabian H. Weissbach ◽  
Marthe Larsen ◽  
Karoline Borgen ◽  
...  

2019 ◽  
Vol 27 (2) ◽  
pp. 199-208
Author(s):  
Valeriu Gheorghiță ◽  
Ion Ștefan ◽  
Ioana Diana Olaru ◽  
Adelina Maria Radu ◽  
Oana Săndulescu ◽  
...  

Abstract Background: The primary goal was to estimate the seroprevalence of autochthonous hepatitis E virus (HEV) infection in adult Romanian population. Additionally, we aimed to identify the risk factors associated with the HEV seropositive status. Methods: Between January 2015 and December 2016, 201 adult patients were tested for antiHEV-IgG. Multivariate logistic regression was used to examine for factors associated with a positive HEV-IgG test. The level of significance was set at α = 0.05. Results: The final analysis included 175 patients who followed the study protocol. Forty-sex (26.3%) had positive, 121 (69.1%) had negative, and 8 (4.6%) had indeterminate antiHEV-IgG results. Patients with positive anti-HEV-IgG were older [median age: 54.5 years (IQR 43-65)] compared to patients with negative anti-HEV-IgG [median age: 37.5 years (IQR 28-57.5)], p <0.001. A positive HEV-IgG was more common in patients with history of blood transfusions [n=10 (22.7%) versus (vs) n=11 (9.4%), p=0.025], in those with immunosuppressive conditions [n=18 (40.9%) vs n=27 (23.1%), p=0.025] and in patients with positive hepatitis B surface antigen (HBsAg) [n=14 (31.1%) vs n=10 (10.3%), p=0.002]. Conclusions: In conclusion, we found that autochthonous HEV seropositivity is common in our study population, especially in older patients, previous blood transfusions, presence of immunosuppressive conditions, and positive HBsAg.


2011 ◽  
Vol 49 (01) ◽  
Author(s):  
C Dorloff ◽  
J Hemberger ◽  
M Odenthal ◽  
H Holzmann ◽  
S Aberle ◽  
...  

2013 ◽  
Vol 51 (01) ◽  
Author(s):  
S Schlosser ◽  
J Pflaum ◽  
K Weigand ◽  
JJ Wenzel ◽  
W Jilg ◽  
...  

2018 ◽  
Vol 56 (01) ◽  
pp. E2-E89
Author(s):  
D Westhölter ◽  
J Hartl ◽  
J Hiller ◽  
U Denzer ◽  
S Peine ◽  
...  

1995 ◽  
Vol 74 (05) ◽  
pp. 1385-1386 ◽  
Author(s):  
Pirkko Pohjanpelto ◽  
Freja Ebeling ◽  
Vesa Rasi ◽  
Hartmut Hampl

Sign in / Sign up

Export Citation Format

Share Document